These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8296656)

  • 1. Identification of apparent dual ANCA specificities in a subset of patients with systemic vasculitis and crescentic glomerulonephritis.
    Teeraratkul P; Thorson JA; Kemp JD; Goeken JA
    Adv Exp Med Biol; 1993; 336():455-9. PubMed ID: 8296656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
    Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
    Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
    Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
    Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p-ANCA with myeloperoxidase antibodies and c-ANCA with proteinase 3 antibodies define a different vasculitis entity in patients with renal involvement.
    Dringenberg C; Apenberg S; Andrassy K
    Adv Exp Med Biol; 1993; 336():445-7. PubMed ID: 8296653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of immunofluorescence and confocal laser scanning microscopy in identifying rare cases of anti-neutrophil cytoplasmic antibodies (ANCA) showing dual specificities to myeloperoxidase and proteinase3.
    Badakere SS; Pradhan VD; Almeida AF; Pawar AR
    J Fluoresc; 2004 Jul; 14(4):459-63. PubMed ID: 15617388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis.
    Franssen CF; Huitema MG; Muller Kobold AC; Oost-Kort WW; Limburg PC; Tiebosch A; Stegeman CA; Kallenberg CG; Tervaert JW
    J Am Soc Nephrol; 1999 Jul; 10(7):1506-15. PubMed ID: 10405206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
    Xin G; Zhao MH; Wang HY
    Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
    Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
    J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a new fluorescent-enzyme immuno-assay for diagnosis and follow-up of ANCA-associated vasculitis.
    Damoiseaux JG; Slot MC; Vaessen M; Stegeman CA; Van Paassen P; Tervaert JW
    J Clin Immunol; 2005 May; 25(3):202-8. PubMed ID: 15981084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
    Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
    Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perinuclear antineutrophil cytoplasmic antibodies (p-ANCA): clinical significance and relation to antibodies against myeloid lysosomal enzymes.
    Tervaert JW; Mulder AH; Kallenberg CG
    Adv Exp Med Biol; 1993; 336():253-6. PubMed ID: 8296614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of ANCA in 98 patients.
    Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
    Adv Exp Med Biol; 1993; 336():273-9. PubMed ID: 7905232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproteinase 3- and antimyeloperoxidase-associated vasculitis.
    Franssen CF; Stegeman CA; Kallenberg CG; Gans RO; De Jong PE; Hoorntje SJ; Tervaert JW
    Kidney Int; 2000 Jun; 57(6):2195-206. PubMed ID: 10844589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-neutrophil cytoplasmic autoantibodies (ANCA): antigenic specificities and clinical associations.
    Bosch X; Font J; Mirapeix E; Revert L; Urbano-Márquez A; Ingelmo M
    Adv Exp Med Biol; 1993; 336():281-6. PubMed ID: 8296618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
    Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
    Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-ANCA and p-ANCA positive vasculitis with crescentic glomerulonephritis: the same clinical feature but different immunological pathways?
    Grotz W; Röther E; Schollmeyer P
    Adv Exp Med Biol; 1993; 336():461-4. PubMed ID: 8296657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of autoantibodies to purified proteinase 3 in systemic vasculitis.
    Gaskin G; Turner AN; Ryan JJ; Rees AJ; Pusey CD
    Adv Exp Med Biol; 1993; 336():287-9. PubMed ID: 8296619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathological manifestations of patients with antineutrophil cytoplasmic autoantibodies directed against proteinase 3 or myeloperoxidase.
    Zhang X; Dong Y; Zeng X; Li Y; Tang F
    Chin Med Sci J; 2002 Mar; 17(1):32-5. PubMed ID: 12894882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha 1-antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis.
    Savige JA; Chang L; Cook L; Burdon J; Daskalakis M; Doery J
    Clin Exp Immunol; 1995 May; 100(2):194-7. PubMed ID: 7743654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of neutrophil responsiveness to myeloperoxidase antibodies by their exposure to supernatant of degranulated autologous neutrophils.
    Hess C; Sadallah S; Schifferli JA
    Blood; 2000 Oct; 96(8):2822-7. PubMed ID: 11023517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.